Date: August 13, 2025

ATLANTA (August 13, 2025) – The Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta received a new $3.3 million gift commitment from CURE Childhood Cancer. Over the past five years, the organization has donated more than $12 million to the Aflac Cancer and Blood Disorders Center.

The majority of CURE’s latest gift is allocated to the Precision Medicine Program at the Aflac Cancer and Blood Disorders Center, which was developed, in part, thanks to a previous gift from CURE in 2017. The Precision Medicine Program uses genetic testing methods to identify specific changes in the DNA and RNA of cancer cells, offering individualized treatment options to our pediatric cancer patients.

Additional funding from CURE has been awarded to the Kelly Goldsmith, MD, Muxiang Zhou, PhD and Manoj Bhasin, PhD for their research related to immunotherapies in pediatric solid tumors and treatment of acute myeloid leukemia.

“We are incredibly grateful to CURE for this generous gift and their continued support of the doctors, researchers and patient families within Children’s,” said Doug Graham, MD, PhD, Chief, Aflac Cancer and Blood Disorders Center. “Thanks to funding from CURE, our Precision Medicine Program has made significant strides over the past few years, and this additional funding will help identify new therapies and treatment options for our patient families in Georgia and around the country.”

The latest gift also will fund the Hematology/Oncology Fellowship Program and provide critical financial assistance for families.

About Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta

The Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta is a national leader among childhood cancer, hematology, and blood and marrow transplant programs, serving children and young adults. Recognized as one of the top childhood cancer centers in the country by U.S. News & World Report, the Aflac Cancer and Blood Disorders Center cares for more than 9,500 patients yearly, of which nearly 500 are newly diagnosed cancer patients and treats more than 2,000 unique sickle cell disease patients each year. Our program offers patients access to more than 330 clinical trials, including 34 innovative Aflac Cancer and Blood Disorders Center investigator-initiated trials. Visit www.choa.org/cancer for more information.

About Children's Healthcare of Atlanta

As the only freestanding pediatric healthcare system in Georgia, Children’s Healthcare of Atlanta is the trusted leader in caring for kids. The not-for-profit organization’s mission is to make kids better today and healthier tomorrow through more than 60 pediatric specialties and programs, top healthcare professionals, and leading research and technology. Children’s is one of the largest pediatric clinical care providers in the country, managing more than one million patient visits annually at three hospitals (Arthur M. Blank, Hughes Spalding and Scottish Rite), Marcus Autism Center, the Center for Advanced Pediatrics, the Zalik Behavioral and Mental Health Center, urgent care centers and neighborhood locations. Consistently ranked among the top children’s hospitals by U.S. News & World Report, Children’s Healthcare of Atlanta has impacted the lives of kids in Georgia, across the United States and around the world for more than 100 years thanks to generous support from the community.

About CURE Childhood Cancer

Founded in 1975, Atlanta, Georgia-based CURE Childhood Cancer is dedicated to conquering childhood cancer through funding targeted research while supporting patients and their families. With cancer as the second leading cause of death in children, CURE dedicates more than $5.6 million annually to specific research projects aimed at curing cancers that affect children. Through innovative programming, CURE Childhood Cancer also provides crisis-oriented support to patients and their families, addressing their most critical and urgent needs. For more information, visit www.curechildhoodcancer.org.